Cambridge Investment Research Advisors, Inc. Lifevantage Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Lifevantage Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,605 shares of LFVN stock, worth $86,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,605
Previous 12,867
17.58%
Holding current value
$86,960
Previous $188,000
26.06%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LFVN
# of Institutions
119Shares Held
6.93MCall Options Held
900Put Options Held
53.4K-
Capital Management Corp1.27MShares$10.4 Million3.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny894KShares$7.33 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA564KShares$4.63 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT446KShares$3.66 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX293KShares$2.4 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $103M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...